melanoma
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.
Loss of <span class="gene" id="24495407-0-8-14">CDKN2A</span> expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in <span class="disease" id="24495407-0-144-152">melanoma</span> cell lines.